ANGO vs BDX · rev $292.5M vs P/E 34, rev $21.84B
AngioDynamics Inc (ANGO) versus Becton Dickinson and Company (BDX) — a side-by-side from cached financials, not a winner call.
AngioDynamics Inc (ANGO) is a medical instruments & supplies company listed on US.
Becton Dickinson and Company (BDX) is a medical instruments & supplies company listed on US.
Latest reported ANGO revenue for 2025-05-31 was $292.5M. Net income was -$34.0M. Revenue was down 3.8% from 2024-05-31 to 2025-05-31. ANGO currently screens at market cap $378.5M.
Latest reported BDX revenue for 2025-09-30 was $21.84B. Net income was $1.68B. Revenue was up 8.2% from 2024-09-30 to 2025-09-30. BDX currently screens at market cap $50.30B and trailing P/E 33.9.
ANGO currently screens at market cap $378.5M. BDX currently screens at market cap $50.30B and trailing P/E 33.9.
Not investment advice. Open the ANGO and BDX stock pages for the full models.
Not investment advice.